ChatDocto
Find a doctor
Two-tone pharmaceutical capsule

ESTIMA 100 mg

Progesterone · soft capsules

B/30Oral use
14,906 DTRecorded public price · B/30
See all pack prices
Strength100 mg
Therapeutic classSYSTEME GENITO URINAIRE ET HORMONES SEXUELLES

About this medicine

ESTIMA 100 mg soft capsules is listed in Tunisia's medicine catalog under the active ingredient Progesterone. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/30

    30 units in this pack

    Recorded public price14,906 DT
    AMM No.
    15603011
    CNAM code
    105050
    CNAM reference amount
    11,940 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formsoft capsules
Route of administrationOral use
LaboratoryEFFIK
OriginGeneric
ScheduleO
Therapeutic classSYSTEME GENITO URINAIRE ET HORMONES SEXUELLES

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

PROGESTERONE MYLAN 100 mgCapsules mollesMYLAN S.A.S · B/30
Recorded public price11,945 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026